Panfacial Botulinum Toxin Improves Patient Retention

February 2007 | Volume 6 | Issue 2 | Original Article | 131 | Copyright © February 2007

Martin Braun MD

Abstract
The injection of botulinum toxin (Botox®, Allergan, Irvine, CA) is the most common cosmetic procedure in the US. In the past 5 years, its use has climbed over 388%. In 2005, business development managers from Allergan audited 1,695 patient charts from the top 54 cosmetic practices in Canada. Despite the increasing popularity of this nonsurgical treatment, on average only 57% of patients return for a second injection within 6 months. In the author’s clinical practice 92% of patients return for a second injection in this time frame. This paper will examine various factors that appear to result in satisfied patients with a high retention rate. This article will show that panfacial botulinum toxin injected in multiple sites with appropriate dosing improves patient retention.